To contribute to studies of cancer health disparities by generating several patient-derived xenograft (PDX) models for non-small cell lung cancer (nsclc) in an immunodeficient RAT model and in…
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261201700017C
- Awardee
-
Hera Testing Laboratories, Inc. UEI JK2VCZCBR8R4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $293,728
Award facts
- Opportunity
-
- PHS20171OMNIBUS Solicitation number
- Contract value 100% obligated
- $293,728.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 8 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Lexington, KY 40508, USA
Award details come from SAM.gov/FPDS.
About this award
This is a definitive, firm fixed-price contract awarded by the National Cancer Institute, part of the Department of Health and Human Services National Institutes of Health, to Hera Testing Laboratories Inc., a for-profit organization. The contract, valued at $293,728.00, is set aside for small businesses.
The purpose of the contract is to contribute to studies of cancer health disparities by generating several patient-derived xenograft (PDX) models for non-small cell lung cancer (NSCLC) in an immunodeficient rat model and in parallel in a mouse model, using tissue specimens from ethnic minority patients. The contract has a completion date of June 18, 2018.
Description
To contribute to studies of cancer health disparities by generating several patient-derived xenograft (PDX) models for non-small cell lung cancer (nsclc) in an immunodeficient RAT model and in parallel in a mouse model using tissue specimens that come from ethnic minority patients.
Quick answers
Who was awarded contract HHSN261201700017C?
HHSN261201700017C was awarded to Hera Testing Laboratories, Inc. by National Cancer Institute (National Institutes of Health) on September 19, 2017.
How much is contract HHSN261201700017C worth?
The government has obligated $293,728 on HHSN261201700017C.
Was contract HHSN261201700017C competed?
The extent of competition for HHSN261201700017C was full and open competition after exclusion of sources. The government received 8 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award